These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 22593995)

  • 21. 99mTc-MIBI in the assessment of response to chemotherapy and detection of recurrences in bone and soft tissue tumours of the extremities.
    Moustafa H; Riad R; Omar W; Zaher A; Ebied E
    Q J Nucl Med; 2003 Mar; 47(1):51-7. PubMed ID: 12714955
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Technetium-99m-MIBI scintigraphy in the assessment of neoadjuvant chemotherapy in breast carcinoma.
    Maini CL; Tofani A; Sciuto R; Semprebene A; Cavaliere R; Mottolese M; Benevolo M; Ferranti F; Grandinetti ML; Vici P; Lopez M; Botti C
    J Nucl Med; 1997 Oct; 38(10):1546-51. PubMed ID: 9379190
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prediction of lack of response to neoadjuvant chemotherapy in rare breast tumour histology with Tc-99m sestamibi scintimammography.
    Sood A; Seam RK; Mardi K; Gupta MK; Sethi S
    Ann Nucl Med; 2011 Aug; 25(7):524-7. PubMed ID: 21476055
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of early 99mTc-MIBI uptake by Bcl-2 anti-apoptotic protein overexpression in untreated breast carcinoma.
    Del Vecchio S; Zannetti A; Aloj L; Caracò C; Ciarmiello A; Salvatore M
    Eur J Nucl Med Mol Imaging; 2003 Jun; 30(6):879-87. PubMed ID: 12721767
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of bilateral, multifocal breast cancer and assessment of tumour response to neoadjuvant chemotherapy by Tc-99m sestamibi imaging - a case report.
    Grosso M; Imran MB; Volterrani D; Roncella M; Abufalgha K; Grassetto G; Al-Nahhas A; Rubello D; Mariani G
    Nucl Med Rev Cent East Eur; 2008; 11(2):70-2. PubMed ID: 19585458
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Tentative results of using 99mTC-methoxyisobutyl isonitrile in predicting the effect of preoperative chemotherapy for locally advanced breast cancer].
    Portnoĭ SM; Odzharova AA; Shiriaev SV; Anurova OA; Laktionov KP; Riabchikov DA
    Vopr Onkol; 2006; 52(6):620-3. PubMed ID: 17338237
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neoadjuvant therapy in locally advanced breast cancer: 99mTc-MIBI mammoscintigraphy is not a reliable technique to predict therapy response.
    Travaini LL; Baio SM; Cremonesi M; De Cicco C; Ferrari M; Trifirò G; Prisco G; Viale G; Colleoni MA; Radice D; Sivolapenko GB; Paganelli G
    Breast; 2007 Jun; 16(3):262-70. PubMed ID: 17291755
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of technetium-99m methoxyisobutyl isonitrile scintigraphy in predicting the therapeutic effect of chemotherapy against nasopharyngeal carcinoma.
    Wang XS; Zhang YJ; Liu XL; Zhou ZR; Hu CS; Eisbruch A
    Cancer; 2011 Jun; 117(11):2435-41. PubMed ID: 24048791
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radioguided occult lesion localisation (ROLL) in breast-conserving surgery after neoadjuvant chemotherapy.
    Donker M; Straver ME; Rutgers EJ; Valdés Olmos RA; Loo CE; Sonke GS; Wesseling J; Vrancken Peeters MJ
    Eur J Surg Oncol; 2012 Dec; 38(12):1218-24. PubMed ID: 22871497
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tc-99m-methoxy isobutyl isonitrile scintimammography: imaging postexcision biopsy for residual and multifocal breast tumor.
    Usmani S; Khan HA; Niaz K; Uz-Zaman M; Niyaz K; Javed A; al Mohannadi S; Abu al Huda F; Kamal S
    Nucl Med Commun; 2008 Sep; 29(9):826-9. PubMed ID: 18677211
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of chemotherapy on the uptake of technetium-99m sestamibi in breast cancer.
    Cwikla JB; Buscombe JR; Barlow RV; Kelleher SM; Parbhoo SP; Crow J; Deery A; Jones AL; Hilson AJ
    Eur J Nucl Med; 1997 Sep; 24(9):1175-8. PubMed ID: 9283114
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of scintimammography in assessing the response of neoadjuvant chemotherapy in locally advanced breast cancer.
    Trehan R; Seam RK; Gupta MK; Sood A; Dimri K; Mahajan R
    World J Nucl Med; 2014 Sep; 13(3):163-9. PubMed ID: 25538487
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Double-phase Tc-99m sestamibi scintimammography to assess angiogenesis and P-glycoprotein expression in patients with untreated breast cancer.
    Yoon JH; Bom HS; Song HC; Lee JH; Jaegal YJ
    Clin Nucl Med; 1999 May; 24(5):314-8. PubMed ID: 10232467
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neoadjuvant chemotherapy for local advanced breast cancer with stage IIIB.
    Kim R; Osaki A; Tanabe K; Toge T
    Oncol Rep; 2004 Jun; 11(6):1265-72. PubMed ID: 15138565
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recurrence rates after DCE-MRI image guided planning for breast-conserving surgery following neoadjuvant chemotherapy for locally advanced breast cancer patients.
    Garimella V; Qutob O; Fox JN; Long ED; Chaturvedi A; Turnbull LW; Drew PJ
    Eur J Surg Oncol; 2007 Mar; 33(2):157-61. PubMed ID: 17085007
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tc-99m sestamibi scintimammography in the evaluation of response of breast carcinoma to chemotherapy.
    Joaquim AI; Sagarra AJ; Ramos CD; Coudry R; Sagarra RA; Camargo EE
    Clin Nucl Med; 1997 Sep; 22(9):638-40. PubMed ID: 9298303
    [No Abstract]   [Full Text] [Related]  

  • 37. Evaluation of changes of biologic markers ER, PR, HER 2 and Ki-67 in breast cancer with administration of neoadjuvant dose-dense doxorubicin, cyclophosphamide followed by paclitaxel.
    Dede DS; Gumuskaya B; Guler G; Onat D; Altundag K; Ozisik Y
    J BUON; 2013; 18(1):57-63. PubMed ID: 23613389
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Uptake of Tc-99m MIBI related to tumour size and type.
    Buscombe JR; Cwikla JB; Thakrar DS; Hilson AJ
    Anticancer Res; 1997; 17(3B):1693-4. PubMed ID: 9179220
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumour size is the only predictive factor of distant recurrence after pathological complete response to neoadjuvant chemotherapy in patients with large operable or locally advanced breast cancers: a sub-study of EORTC 10994/BIG 1-00 phase III trial.
    Fei F; Messina C; Slaets L; Chakiba C; Cameron D; Bogaerts J; Bonnefoi H
    Eur J Cancer; 2015 Feb; 51(3):301-9. PubMed ID: 25578377
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of
    Moulika JS; Kalawat T; Manthri RG; Hulikal N; Kadiyala S; Bhargavi D; Prayaga AK
    Indian J Nucl Med; 2023; 38(4):354-361. PubMed ID: 38390549
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.